BRCA1 and colorectal cancer: Ford et al. [19] and Thompson et al. [32] investigated CRC risk among BRCA1 mutation carriers, whereas Suchy et al. [31] genotyped 2,398 unselected patients with colorectal cancer and 4,570 controls from Poland for three BRCA1 founder mutations.